Carregant...
Status of group B streptococcal vaccine development
Streptococcus agalactiae (group B streptococcus, GBS) is a leading causal organism of neonatal invasive diseases and severe infections in the elderly. Despite significant advances in the diagnosis and treatment of GBS infections and improvement in personal hygiene standards, this pathogen is still a...
Guardat en:
| Publicat a: | Clin Exp Vaccine Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Vaccine Society
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795048/ https://ncbi.nlm.nih.gov/pubmed/29399583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7774/cevr.2018.7.1.76 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|